Feed:All articles/Pretty: Difference between revisions

Jump to navigation Jump to search
no edit summary
No edit summary
No edit summary
Line 1,522: Line 1,522:
             "title" : "Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease",
             "title" : "Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease",
             "pmid" : "17108343"
             "pmid" : "17108343"
        },
        {
            "timestamp" : "2018-11-30T20:42:52Z",
            "briefDesignDescription" : "Low-dose MTX for secondary prevention of CAD",
            "fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa1809798",
            "pageid" : 3739,
            "pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa1809798",
            "trainingLevel" : "Resident",
            "citation" : "Ridker PM, <i>et al</i>. \"Low-dose methotrexate for the prevention of atherosclerotic events\". <i>The New England Journal of Medicine</i>. 2018. epub 2018-11-10:1-11.",
            "subspecialties" : "Cardiology",
            "expansion" : "Cardiovascular Inflammation Reduction Trial",
            "statusUsableDate" : "2018-11-14",
            "briefResultsDescription" : "Low-dose methotrexate not superior to placebo for secondary prevention of CAD",
            "published" : "2018-11-10",
            "pageName" : "CIRT",
            "diseases" : "Coronary artery disease",
            "abbreviation" : "CIRT",
            "title" : "Low-dose methotrexate for the prevention of atherosclerotic events",
            "pmid" : "30415610"
         },
         },
         {
         {
Line 2,187: Line 2,206:
             "title" : "Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction",
             "title" : "Prophylactic use of an implantable cardioverter–defibrillator after acute myocardial infarction",
             "pmid" : "15590950"
             "pmid" : "15590950"
        },
        {
            "timestamp" : "2018-11-30T20:44:41Z",
            "briefDesignDescription" : "BMS vs. DES for saphenous vein graft PCI",
            "fulltexturl" : "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)30801-8/fulltext",
            "pageid" : 3743,
            "pdfurl" : "",
            "trainingLevel" : "Resident",
            "citation" : "Brilakis ES, <i>et al</i>. \"Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial\". <i>Lancet</i>. 2018. 391(10134):1997-2007.",
            "subspecialties" : "Cardiology",
            "expansion" : "Rationale and design of the drug-eluting stents vs bare-metal stents in saphenous vein graft angioplasty",
            "statusUsableDate" : "2018-11-27",
            "briefResultsDescription" : "BMS noninferior to DES for saphenous vein graft PCI",
            "published" : "2018-05-19",
            "pageName" : "DIVA",
            "diseases" : "Coronary artery disease",
            "abbreviation" : "DIVA",
            "title" : "Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial",
            "pmid" : "29759512"
         },
         },
         {
         {
Line 3,935: Line 3,973:
             "title" : "Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets",
             "title" : "Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets",
             "pmid" : "23942679"
             "pmid" : "23942679"
        },
        {
            "timestamp" : "2018-11-30T21:53:12Z",
            "briefDesignDescription" : "Antipsychotics in ICU delirium",
            "fulltexturl" : "https://www.nejm.org/doi/full/10.1056/NEJMoa1808217",
            "pageid" : 3741,
            "pdfurl" : "https://www.nejm.org/doi/pdf/10.1056/NEJMoa1808217",
            "trainingLevel" : "resident",
            "citation" : "Girard TD, <i>et al</i>. \"Haloperidol and ziprasidone for treatment of delirium in critical illness\". <i>The New England Journal of Medicine</i>. 2018. ePub 2018-10-22:1-12.",
            "subspecialties" : "Psychiatry;Critical Care",
            "expansion" : "Modifying the Impact of ICU-Associated Neurological Dysfunction–USA",
            "statusUsableDate" : "2018-11-30",
            "briefResultsDescription" : "Antipsychotics don't reduce days without delirium or coma in ICU",
            "published" : "2018-10-22",
            "pageName" : "MIND-USA",
            "diseases" : "Delirium;Critical Illness",
            "abbreviation" : "MIND-USA",
            "title" : "Haloperidol and ziprasidone for treatment of delirium in critical illness",
            "pmid" : "30346242"
         },
         },
         {
         {
Bots, editor, reviewer, Administrators
13,951

edits

Navigation menu